Blau syndrome with good reponse to tocilizumab: A case report and focused literature review

The objective of this study is to describe a case of BS benefit from Tocilizumab, a humanized monoclonal antibody against interleukin 6 receptor.

Source: Seminars in Arthritis and Rheumatism - September 25, 2017 Category: Rheumatology Authors: Li Lu, Min Shen, Dongbin Jiang, Yanmin Li, Xiaolong Zheng, Yao Li, Zhixun Li, Leilei Zhang, Jungen Tang, Yanke Guo, Shengyun Liu, Zhaohui Zheng, Guanmin Gao, Quancheng Kan Source Type: research